Welcome to ICVrx's investor site.
ICVrx, LLC is a company that is developing a novel method of treating serious diseases of the Central Nervous System (CNS), including refractory epilepsy.
ACCREDITED INVESTOR REPRESENTATION
ICVrx is offering its securities solely to accredited investors. By entering this site, you agree to the following:
I confirm that I am an accredited sophisticated investor, and that ICVrx has agreed to provide me access to any and all information that may help me make an informed investment decision, including this website. I have read, or will read, the Private Placement Memo (inclusive of the risk factors), operating agreement, business plan, and other documents provided by ICVrx, and recognize the risk of loss of my potential investment and represent that I can afford that risk.
Investor Contact Information:
James (Jim) E. Hock
760-561-7400 phone or 303-547-3448 voicemail and fax
Accredited, Registered investors may access this site by clicking on the "Logon" icon, after receiving a logon/password by contacting James E. Hock.
| ICVrx 2010. All rights reserved. |
